Lataa...

SUN-180 Successful Use of SGLT-2 Inhibitor Dapagliflozin in Three Patients with Renal Transplant and Diabetes: A Fruit for Thoughts

Background: Management of patients with diabetes and renal transplant could be challenging. Transplant patients use multiple immune suppressants; most of them are notorious in worsening or even trigger hyperglycemia. Many of these patients have to use multiple anti-hyperglyemic agents to attain adeq...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Endocr Soc
Päätekijät: Elhadd, Tarik, Naem, Emad, Elawad, Safa, Tanouri, Dali, Bdair, Ahmed
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Endocrine Society 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553257/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-180
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!